Navigation Links
WebMD Announces Third Quarter Financial Results
Date:11/3/2009

des the most comprehensive drug information, clinical reference tools, medical news and continuing medical education on a mobile device. It is the only mobile application to deliver specialty-specific news and medical education, leveraging Medscape's assets and award winning professional editorial team. Development is underway to launch new product enhancements and additional mobile platforms including BlackBerry® later this year. Mr. Gattinella said, "Medscape Mobile continues to rank at the top of the App Store for medical applications, with already over 200,000 downloads since launching three months ago."

WebMD Launches Healthy Pets

In October, WebMD launched the WebMD Healthy Pets channel on WebMD.com, which provides pet owners with the latest health and wellness information to help their pets live healthier lives. WebMD Healthy Pets provides veterinarian-reviewed information on pet diet and nutrition, behavior and training, and preventive care. More than 75% of WebMD users are pet owners who also care for the health of their pets and nearly $700 million is spent annually on marketing pet supplies and services in the U.S. Mr. Gattinella said, "We continue to invest in new markets that have the opportunity to significantly expand our user base and penetrate new areas of revenue opportunity for the future."

Merger with HLTH Completed

As previously announced, WebMD and HLTH completed their merger on October 23, 2009. The applicable accounting treatment for the merger results in HLTH being treated as the acquiring entity and, as a result, the pre-acquisition consolidated financial statements of HLTH will become the historical financial statements of WebMD beginning with reporting for the fourth quarter of 2009. WebMD is furnishing, as Exhibit 99.5 to the Current Report on Form 8-K filed with the SEC by WebMD today, a copy of HLTH's financial information for the third quarter of 2009.

As
'/>"/>

SOURCE WebMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. FDA and WebMD Expand Consumer Health Information Partnership
2. WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference
3. WebMD Announces Second Quarter Financial Results
4. WebMD Launches Free Mobile Application For Physicians
5. HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call
6. HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge
7. WebMD to Present at Jefferies 3rd Annual Healthcare Conference
8. COPD Foundation announces launch of Lung Health Check on WebMD
9. HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call
10. WebMD Announces Strategic Relationship with Boots UK to Launch New Consumer Health Portal in UK
11. WebMD to Present at the Morgan Stanley Technology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...-- The National Cancer Institute has awarded a $55...son Cancer Research Center to become the nation,s ...ntact Center. ,, The move will create 60 new jo...size of its current CIS workforce - once the conso...duled for March 15, 2010. The Seattle CIS center w...
(Date:12/4/2009)...ogress has been made over the last 15 years in the...eat epilepsy and its complications. Yet this prog...f the 50 million people around the world, includin...nited States who have the disorder, , According ...rican Epilepsy Society (AES), there is an enormous...
(Date:12/4/2009)...mp; Author and Political Analyst Leslie Sanchez pr...ng Providence Hospital’s “Adopt-a-Fami...ise $5000 in cash and toy donations for the charit...ll match the donation. Toys will be distributed to...spital. , Washington, DC...
(Date:12/4/2009)...commend its use, experts say , , , FRID...aucoma patients and others can benefit from medica...can help multiple sclerosis (MS) patients find rel...f the debilitating autoimmune disease. , "The t... to be comprehensive, and should be given consider...
(Date:12/4/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...present results from five studies at the 32nd Annu...king place December 9-13, 2009, at the Henry B. Go...lyze Onco type DX®, the company,s multi-gene...predict the likelihood of chemotherapy benefit as ...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4
... 21 The Generic,Pharmaceutical Association (GPhA)...President and CEO Kathleen Jaeger regarding the Fe...ng Health Care Competition and Consumer Issues." ,...and,affordable biogenerics sooner rather than late...
...e University of Texas M. D. Anderson Cancer Cent...to eradicate breast cancer in Panama through the P...h of the Americas today at an event with Laura Bus...are the U.S. Department of State and Susan G. Kome...
... 21 U.S. News & World Report and the National...eChoice(R) HealthPlan of South Carolina in the top...ed in U.S. News & World Report,s issue this we...cores. NCQA and U.S. News & World Report ranke...
...r drugs do not cause genetic damage that can lead ...News) -- Two popular medications for treating atte... cause genetic damage linked to an increased risk ...nters a previous one that reported biomarkers asso...
...PRNewswire/ -- For the second year in a row and ...althcare Worldwide,s agency network won more creat...nd annual international RX Club Show. , , Ni...thcare Worldwide agencies include Caudex Medical, ...
...co use is more prevalent and smoking cessation les...ractivity Disorder (A.D.H.D.) In a study of smoke...ms, those who exhibited elevated hyperactivity and....D. symptoms. The study, now available online in ...
Other Medicine News:Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
(Date:12/4/2009)... , HOUSTON, Dec. 4 OrthoAccel T...ystem , which is an acceleration device to enhance... Continuing Education course published by PennWel... for many industries, including medicine and denti...rthodontic treatment, a summary of treatment biome...
(Date:12/4/2009)... Md., Dec. 4 Drs. Neal Shore and E...ecific antigen (PSA) recurrence from the additiona...recurrence rate in a Phase III pivotal study of FI...monthly leuprolide in prostate cancer patients dur...patients who received FIRMAGON 240/80 mg/month had...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety ...ractivity Disorder (ADHD), sleep disorder and migr...o occur more often in people who said they had bee...epilepsy diagnosis, according to a survey of appro...Findings from " CNS-Related Comorbidities in Indiv...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 1Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 2Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 3Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 4Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection 55707 5Vitality Health LLC Joins HealthySkinPortal Network 55704 1Vitality Health LLC Joins HealthySkinPortal Network 55704 2Foldaway Pediatric Point of Care Table Provides Efficient Work Surface Without Compromising Space 55701 1Foldaway Pediatric Point of Care Table Provides Efficient Work Surface Without Compromising Space 55701 2
... Against Difficult-to-Treat Skin Infections...tant Staphylococcus aureus (MRSA), NEW YORK, June... announced positive results from two globally cond...e, a broad-spectrum,cephalosporin with activity ag...m negative bacteria, for the treatment of complica...
... using cloned cells alone ... describe the first,successful use of a human pati...e therapy to put an advanced solid-tumor cancer in... M.D., an associate member of the,Clinical Researc...er,reports these findings in the June 19 issue of ...
Other Medicine Technology:Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 2Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 3Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections 4Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3
Premier Lock 'n Roll Drainable Pouch, Pre-Sized Convex Flextend Skin Barrier, with Tape
Premier Lock 'n Roll Drainable Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Premier High Output Pouch Non-Sterile
Premier Closed Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Medicine Products: